Increased C5a receptor expression in sepsis

Journal of Clinical Investigation

Volumn 110, Issue 1, 2002, Pages 101-108

  Riedemann, Niels C ^a   Guo, Ren Feng ^a   Neff, Thomas A ^a   Laudes, Ines J ^a   Keller, Katie A ^a   Sarma, Vidya J ^a   Markiewski, Maciej M ^b   Mastellos, Dimitrios ^b   Strey, Christoph W ^b   Pierson, Carl L ^a   Lambris, John D ^b   Zetoune, Firas S ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; IMMUNOGLOBULIN G; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CELL PROTECTION; CELL SURVIVAL; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY; LIVER; LUNG; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SEPSIS;

EID: 0036304968     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215409     Document Type: Article

References (34)

1. Protective effects of C5a blockade in sepsis
2. Endotoxin-induced shock in the rat. A role for C5a
3. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis
4. Role of C5a in multiorgan failure during sepsis
5. Protective effects of anti-C5a peptide antibodies in experimental sepsis
6. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement
7. Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes
8. Oxygen radicals mediate endothelial cell damage by complementstimulated granulocytes. An in vitro model of immune vascular damage
9. The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo
10. Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement
11. Characterization of a receptor for C5a anaphylatoxin on human eosinophils
12. The chemotactic receptor for human C5a anaphylatoxin
13. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes
14. Expression of the anaphylatoxin C5a receptor in non-myeloid cells
15. Cellular expression of the C5a anaphylatoxin receptor (C5aR): Demonstration of C5aR on nonmyeloid cells of the liver and lung
16. Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: Enhancement of C5amediated release of IL-8 upon exposure to cigarette smoke
17. Induction of functional anaphylatoxin C5a receptors on hepatocytes by in vivo treatment of rats with IL-6
18. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells
19. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system
20. Human T cells express the C5a receptor and are chemoattracted to C5a
21. Identification of the C3b receptor-binding domain in third component of complement
22. Iodination of chemokines for use in receptor binding analysis
23. Expression of C5a receptor in mouse brain: Role in signal transduction and neurodegeneration
24. Analysis of the tissue distribution of the rat C5a receptor and inhibition of C5a-mediaced effects through the use of two MoAbs
25. The C5a receptor is expressed by human renal proximal tubular epithelial cells
26. Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphotoxin-alpha following closed head injury in mice
27. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury
28. A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats
29. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist
30. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma
31. High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines
32. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome
33. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity
34. C5a receptor and thymocyte apoptosis in sepsis